AR
Arvee Laboratories (India) Ltd.
ARVEE.NS · NSE
₹173.42 +0.78% (+₹1.34)
1M +4.98%
Market Cap ₹1.88B
P/E Ratio 46.51x
Div. Yield -
ROE 12.42%
Bulios Fair Price
₹130.99
24.5% downside
Current Price
₹173.42
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ARVEE.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
3/9Valuation
14 /100
Expensive P/B 5.58x
P/S 4.57x
P/E 46.51x
Growth
35 /100
Stable Rev. growth 1.54%
Book val. growth 9.30%
EPS growth 5.90%
Profitability
61 /100
Moderate FCF margin 0.00%
Op. margin 9.96%
Gross margin 34.27%
Quality
77 /100
Excellent ROE 12.42%
ROA N/A
Asset turnover N/A
Debt
100 /100
Low Int. coverage 16.92x
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Stability
35 /100
Moderate Profitable years 6
EPS volatility 93.53%
Beta 0.55x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ARVEE.NS
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Shalin Sudhakarbhai Patel
Employees
57
Headquarters
Ahmedabad